medigraphic.com

2001, Number S1

<< Back Next >>

Arch Cardiol Mex 2001; 71 (S1)

Parcial treatment of terminal heart failure

Fernández de la Reguera G

Language: Spanish
References: 8
Page: 51-53
PDF size: 32.35 Kb.


ABSTRACT

Terminal heart failure with no response to pharmacological treatment has been a challenge in medical practice: besides its deleterious effects on quality of life for all patients, it has a very high mortality rate. At present, surgical treatment of terminal heart failure consist basically in cardiac transplantation, which demands precise surgical indications, donor and receptor selection and adequate immunosupression. Cardiac transplantation has contributed lewer mortality rate and quality of life. Other surgical procedures that have been tried include cardiomioplasty, partial left ventriculectomy (Batista’s surgical procedure) and the use of several left ventricular mechanical devices.


REFERENCES

  1. RANDAS BATISTA: Partial left ventriculectomythe Batista procedure. Eur J Cardio-Thoracic Surgery 1999; 15(S1): 12-19.

  2. JEFFREY DH, LEAH EB, BERKELEY MK, BENNIE F, MARK MB, RICHARD JN: The registry of the international society for heart and lung transplantation: sixteenth official report -1999. Journal of Heart and Lung Transplantation 2000; 18(7): 611-626.

  3. HENRY DT, WILLIAM DE: Pathology of cardiac transplantation: Recipient hearts (chronic heart failure) and donor hearts (acute and chronic rejection). Mayor Clin Porc 1992; 67: 685 696.

  4. GRIDELLI B, REMUZZI G: Strategies for making more organs available for transplantation. N Engl J Med: 2000; 343: 404-410.

  5. BENIAMINOVITZ A, ITESCU S, LIETZ K, DONOVAN M, BURKE E, GROFF B, ET AL: Prevention of rejection in cardiac transplantation by blockade of the interleukin-2 receptor with a monoclonal antibody. N Engl J Med 2000; 342: 613-9.

  6. LIVI U, CAFORIO P: Heart donor management and expansion of current donor selection criteria. J Heart Lung Transplant 2000; 19: S43-S48.

  7. TAYLOR DO: Immunosuppressive therapies after heart transplantation: best, better, and beyond. Curr Opin Cardiol 2000; 15: 108-114.

  8. DELVES PJ, ROITT IM: The immune system. N Engl J Med 2000; 343: 37-49 y 108-117.




2020     |     www.medigraphic.com